HR

Stock splits

$HR chatter on StockTwits

• 
  Stocktwits Earnings@StocktwitsEarningsJul 30

  $HR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.13 up 71.11% YoY • Reported revenue of $278.58M down -5.26% YoY

  View on StockTwits ↗
• 
  Sniper Alpha Research@SniperAlphaComJul 30

  $HR — Trailing Stop Update #1 The breakout has been validated, and price continues to build above the key level. With the position progressing, the trailing stop is now raised to $20.10. The goal isn’t to predict the top—it’s to give a strong trend room to work while gradually reducing downside risk. Manage the structure, not every candle.

  View on StockTwits ↗
• 
  Stocks_Spot@Stocks_SpotJul 28

  $HR heads into its most important update of the quarter. Healthcare Realty will report Q2 results after the close on July 30, 2026, with the earnings call scheduled for July 31. Expectations matter because management raised 2026 normalized FFO guidance on April 30 to $1.59-$1.65 per share and lifted same-store cash NOI growth guidance to 3.75%-4.75%. I will be watching occupancy, leasing spreads and leverage rather than the GAAP headline alone. In Q1, HR repurchased $100 million of stock at an average $17.38 while reporting net debt to adjusted EBITDA of 5.5x. The key question is whether operating improvement can continue without weakening the balance sheet. $DOC remains a useful public-market comparison for medical real estate sentiment. Not financial advice. Do your own research.

  View on StockTwits ↗
• 
  GP@gpaisaJul 18

  Please don't call $HR on me, but rounded bottoms are great.

  View on StockTwits ↗
• 
  Stocktwits Relative Strength@STRelativeStrengthJul 14

  $HR undiscovered breakout with 342 watchers

  View on StockTwits ↗
• 
  SuperGreenToday@SuperGreenTodayJun 16

  $HR Share Price: $20.52 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $0.89 – $1.10 Target Zone: $1.60 – $1.96 Potential Upside: 69% ROI Time to Expiration: 156 Days | Updates via https://fxcapta.com/stockinfo/

  View on StockTwits ↗
• 
  Hbo Fam@HboFamJun 4

  $RVMD $SLS $HR

  View on StockTwits ↗
• 
  Ben@summerof08BullishJun 4

  $HR $RVMD $SLS

  View on StockTwits ↗
• 
  Dew' Moore@dewmooreJun 4

  Remember this past Sunday at ASCO? The entire auditorium erupted into a standing ovation for $RVMD. Their "homerun" hazard ratio printed at **0.40**, completely doubling pancreatic cancer survival to 13.2mo vs 6.6mo. It was history in the making. 🚀 Now look at $SLS, the FDA approval bar for their Phase 3 REGAL trial is an $HR of 0.636. soo if Best Available Therapy (BAT) holds at the historical 8.0 months: **The "Good" Win:** GPS hits **12.6 months** HR = 0.636 rock-solid FDA approval. **THE GRAND SLAM:** If GPS hits the **20 to 24-month mark** (just like it did in Phase 2), the HR plummets **0.33 to 0.40 range** matches or beats the $RVMD bar, flips the AML world on its f*ckin head, and SLS$ goes to the moon. 🌌 $RVMD sits at $33.6B $SLS now has 196.6M shares outstanding—making its share structure incredibly close to $RVMD. If we print a grand slam 0.40s and hit full valuation parity with $RVMD, $SLS doesn't just hit $25 or $50... mathematically, we fly straight to $171.00

  View on StockTwits ↗
• 
  AXLFI_HQ@AXLFI_HQMay 21

  $HR Large-cap companies maintain robust capital market access for debt refinancing and equity raises, while small-cap and emerging companies face elevated borrowing costs, equity dilution, and reliance on specialized lenders. Learn more: https://axlfi.com/themes/289

  View on StockTwits ↗
• 
  AXLFI_HQ@AXLFI_HQMay 20

  $HR Large-cap companies maintain robust capital market access for debt refinancing and equity raises, while small-cap and emerging companies face elevated borrowing costs, equity dilution, and reliance on specialized lenders. Learn more: https://axlfi.com/themes/289

  View on StockTwits ↗
• 
  Billioner@BillionerOfKingMay 12

  $HR Current Stock Price: $19.86 Contracts to trade: $20.0 HR May 15 2026 Call Entry: $0.32 Exit: $0.59 ROI: 87% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

  View on StockTwits ↗
• 
  Stocktwits Earnings@StocktwitsEarningsApr 30

  $HR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.00 • Reported revenue of $275.28M down -6.76% YoY • Healthcare Realty increased its 2026 Normalized FFO guidance range to $1.59 to $1.65 per share (diluted) and raised its Same Store Cash NOI growth guidance range to 3.75% to 4.75%.

  View on StockTwits ↗
• 
  Clover Help@CloverxyzBullishMar 13

  $SMRT what if $HR buy $SMRT

  View on StockTwits ↗
• 
  Victor Perez@Charterdi3Mar 10

  $HR awesomeness, fundamentals on point 🖍️💪 $UNH where you at ?? 🏅🫟

  View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.